Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02650804
Title BPM31510 Administered Intravenously With or Without Gemcitabine in Advanced Pancreatic Cancer Patients
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Berg, LLC

pancreatic adenocarcinoma


BPM 31510

BPM 31510 + Gemcitabine

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.